Analysed CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) News Sources
Is Chugai Pharmaceutical (TSE:4519) Still Attractively Priced After Its Strong Multi Year Run
13-04-2026
yahoo.com
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update
26-03-2026
yahoo.com
Why Sarepta Therapeutics (SRPT) Is Down 11.2% After CEO Retirement Plan And Japan Gene Therapy Launch - And What's Next
01-03-2026
yahoo.com
Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer
28-01-2026
yahoo.com
Assessing Chugai Pharmaceutical (TSE:4519) Valuation Following Strong Share Price Gains
11-11-2025
yahoo.com
What is the current price of CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS)?
The current price of CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) is $26.8.
CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) since the previous trading day is $-1.14.
CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) since the previous trading day is -4.0802%.
What is the most recent average sentiment score for CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS)?
The most recent average sentiment score for CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) is 64 out of 100.
What is the most recent average sentiment for CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS)?
The most recent sentiment for CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS) is .
SEC-8K** Filing Available For CHUGAI PHARMACEUTIC-UNSP ADR (CHGCY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.